Cronos Group Jumps On Rumor Of Acquisition Talks With Curaleaf

Cronos Group (TSX: CRON) jumped as much as 20% in mid-day trading today following the release of a rumor by Reuters that the Altria Group (NYSE: MO) backed cannabis producer might be exploring a sale.

The exploration of a sale is said to follow the attraction of acquisition interest from peers in the industry, including Curaleaf Holdings (CSE: CURA). The company is said to be working with a financial advisor to examine the interest received from the multistate operator.

Both cannabis operators reportedly refused to comment on the rumor, while the source of the rumor requested anonymity due to the confidential nature of the discussions.

READ: Canopy Growth Gets Hit With Multiple $0.00 Price Targets

Whether an offer ultimately surfaces remains to be seen, with no mention being made of the price to be paid. At last count, Cronos had a market value of approximately C$972 million, although that has fluctuated since the report initially came out.

Cronos Group last traded at $2.70 on the TSX.


Information for this briefing was found via Reuters. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Silver47 Eyes Discovery in Nevada After Tripling Kennedy Project Footprint

Total Metals Secures High Grade Critical Minerals Property In Northwestern Ontario

Related News

Curaleaf’s Alabama Cannabis License Application May Have Used A Dead Applicant

Curaleaf’s attempt to obtain a medical cannabis license in Alabama has been met with controversy...

Saturday, September 23, 2023, 11:52:00 AM

Curaleaf: Cormark Upgrades To Buy Rating, Canaccord, Haywood Raise Price Targets

After Curaleaf’s (CSE: CURA) record-breaking second-quarter numbers, analysts have upgraded their twelve-month price targets. Curaleaf...

Wednesday, August 19, 2020, 11:29:55 AM

Curaleaf Q1 2023 Financials: Higher Revenue, Lower Margins, Wider Losses

Curaleaf Holdings (CSE: CURA) reported its Q1 2023 financials late last night, just days after...

Thursday, May 18, 2023, 08:57:18 AM

Curaleaf Records $317.1 Million In Q3 2021 Revenue, Net Loss

Curaleaf Holdings (CSE: CURA) this evening reported its third quarter 2021 financial results, posting revenues...

Monday, November 8, 2021, 04:25:03 PM

Curaleaf Holdings To Raise C$275.6 Million Via Overnight Marketed Offering

Curaleaf Holdings (CSE: CURA) this morning released the pricing of its previously announced overnight marketed...

Thursday, January 7, 2021, 10:14:18 AM